NAFLD / NASH: Hepatic steatosis reversal and liver inflammation pathway research
PMID: 29422987
Lazzati A, Iannelli A, Schneck AS, et al
Reestablishing the cellular metabolic homeostasis in SARS-CoV-2 infection and COVID-19 disease especially in the lungs, could become paramount to balance altered innate and adaptive immunity and cell function and reduce morbimortality (Hsu et al., 2022
The NHS does not currently recommend GLP-1 receptor agonists for the treatment of Hashimoto's thyroiditis or any thyroid condition in the absence of concurrent type 2 diabetes or obesity meeting specific criteria
Safety outcomes: examined odds of hypoglycemic events using administrative codes validated in prior studies 55,56 and gastrointestinal symptoms (constipation, diarrhea, change in bowel habits, abdominal pain, or ileus) during follow up period using administrative codes, as described in prior publications 57